Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
amalgamation, arrangement, bid, bioresearch, CDC, clearance, coercive, driven, Eastern, holder, percent, remeasurement, rescheduled, retention, routine, takeover, tender, void, worsening
Removed:
acquiree, acquirer, adult, Allergy, asserted, biotherapeutic, brand, California, closed, Concurrent, confusion, converted, deducting, demonstrating, domain, fill, formulate, frozen, generic, impeding, incorporate, ineffective, inflammatory, initiated, insolvency, inspect, Institute, live, location, long, measured, modify, NIAID, NIH, November, package, pediatric, postponed, ratio, recognition, registrant, reimburse, renamed, represented, resumed, retrospectively, round, safely, separate, split, statistically, surviving, Telluride, thousand, Torrance, uncured, underwriting, unregistered, written
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view